Affiliation:
1. Laboratory of Future Nanomedicines & Theoretical Chronopharmaceutics, Division of Pharmaceutical Science, School of Pharmacy, University of Missouri-Kansas City, MO 64110, USA
Abstract
Once metastatic, melanoma remains one of the most aggressive and morbid malignancies. Moreover, in past decades, the overall survival for advanced unresectable melanoma exhibited a constancy of poor prognosis. Low response rates and serious adverse effects have been characteristic of standard therapy based on a combination of chemotherapeutic agents or immunotherapy with IL-2. For example, the chemotherapy including dacarbazine, carmustin, cisplatin and tamoxifen is known as ‘Dartmouth regimen’ while the CVD regimen comprises carmustine, vinblastine and dacarbazine. Thus, there is an urgent and critical need to reformulate these bioactive agents using nanoscience and nanotechnology as alternative strategies. This article overviews current design and evaluation of nanomedicine undertaken to address this unmet medical need. The nanomedicines studied include polymeric nanoparticles, liposomes, polymersomes, dendrimers, cubosomes, niosomes and nanodiamonds. In this preclinical article, nanotechnology provides hope for effective treatment of this aggressive and largely treatment-resistant disease.
Subject
Development,General Materials Science,Biomedical Engineering,Medicine (miscellaneous),Bioengineering
Reference125 articles.
1. SEER Cancer Statistics Review, 1975–2007. Altekruse, SF, Kosary CL, Krapcho Met al.(Eds). Bethesda, MD, USA.
2. WHO, Sunbeds, tanning and UV exposure, in Fact sheet N°287.World Health Organization, 2010.
3. The Environmental Protection Agency's National SunWise School Program: Sun protection education in US schools (1999-2000)
4. Mohs Micrographic Surgery: A Historical Perspective
Cited by
73 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献